iopromide has been researched along with Adrenocortical Carcinoma in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SY | 1 |
| Park, BK | 1 |
| Park, JJ | 1 |
| Kim, CK | 1 |
1 other study available for iopromide and Adrenocortical Carcinoma
| Article | Year |
|---|---|
CT sensitivities for large (≥3 cm) adrenal adenoma and cortical carcinoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Contrast Media; Female; Hum | 2015 |